Monday, June 8, 2026
Patent

US 2010273803

Oral Formulations for Tetrapyrrole Derivatives

granted A61K 8/ 49 A IA61K 9/ 00 A IA61K 9/ 127 A I

Quick answer

US patent 2010273803 (Oral Formulations for Tetrapyrrole Derivatives) held by CERAMOPTEC IND INC [DE] expires Wed Oct 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CERAMOPTEC IND INC [DE]
Grant date
Thu Oct 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Wed Oct 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
CPC classes
A61K 8/ 49 A I, A61K 9/ 00 A I, A61K 9/ 127 A I, A61K 31/ 40 A I, A61K 31/ 409 A I